Bevacizumab Downregulates miR-30b-5p, miR-143-3p and miR-192-5p, Leading to SERPINE1/PAI-1 Upregulation Which Results in Acquisition of Bevacizumab Resistance in Ovarian Cancer.

Mayuko Miyamoto

[ISP-022] Bevacizumab Downregulates miR-30b-5p, miR-143-3p and miR-192-5p, Leading to SERPINE1/PAI-1 Upregulation Which Results in Acquisition of Bevacizumab Resistance in Ovarian Cancer.

Mayuko Miyamoto, Kenjiro Sawada, Masaki Kobayashi, Aasa Shimizu, Misa Yamamoto, Taro Yagi, Tadashi Kimura (Obstetrics and gynecology, Osaka University, Osaka, Japan)

抄録パスワードを入力してください。
パスワードは、会員各位へ事前にメール配信しております。

講演情報

ISポスター発表5 IS5

[ISP-022] Bevacizumab Downregulates miR-30b-5p, miR-143-3p and miR-192-5p, Leading to SERPINE1/PAI-1 Upregulation Which Results in Acquisition of Bevacizumab Resistance in Ovarian Cancer.

パスワード